PL1653930T3 - Sposoby stabilizacji atorwastatyny - Google Patents

Sposoby stabilizacji atorwastatyny

Info

Publication number
PL1653930T3
PL1653930T3 PL04738465T PL04738465T PL1653930T3 PL 1653930 T3 PL1653930 T3 PL 1653930T3 PL 04738465 T PL04738465 T PL 04738465T PL 04738465 T PL04738465 T PL 04738465T PL 1653930 T3 PL1653930 T3 PL 1653930T3
Authority
PL
Poland
Prior art keywords
kpa
stabilization
preferably less
partial pressure
gaseous mixture
Prior art date
Application number
PL04738465T
Other languages
English (en)
Inventor
Pavel Sebek
Alena Prokopova
Eduard Svoboda
Stanislav Radl
Jan Stach
Martin Svoboda
Andrej Kovacik
Adrian Danko
Roman Petro
Miroslav Strizinec
Original Assignee
Zentiva Ks
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34117186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1653930(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CZ20032135A external-priority patent/CZ295027B6/cs
Priority claimed from CZ20040857A external-priority patent/CZ296181B6/cs
Application filed by Zentiva Ks filed Critical Zentiva Ks
Publication of PL1653930T3 publication Critical patent/PL1653930T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
PL04738465T 2003-08-05 2004-08-05 Sposoby stabilizacji atorwastatyny PL1653930T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CZ20032135A CZ295027B6 (cs) 2003-08-05 2003-08-05 Způsob stabilizace farmaceutické kompozice
CZ20040857A CZ296181B6 (cs) 2004-08-03 2004-08-03 Zpusob stabilizace farmaceutické úcinné tuhé látky atorvastatinu
EP04738465A EP1653930B1 (en) 2003-08-05 2004-08-05 Methods for the stabilization of atorvastatin
PCT/CZ2004/000045 WO2005011638A2 (en) 2003-08-05 2004-08-05 Methods for the stabilization of atorvastatin

Publications (1)

Publication Number Publication Date
PL1653930T3 true PL1653930T3 (pl) 2008-06-30

Family

ID=34117186

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04738465T PL1653930T3 (pl) 2003-08-05 2004-08-05 Sposoby stabilizacji atorwastatyny
PL379195A PL379195A1 (pl) 2003-08-05 2004-08-05 Sposoby stabilizacji atorwastatyny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL379195A PL379195A1 (pl) 2003-08-05 2004-08-05 Sposoby stabilizacji atorwastatyny

Country Status (13)

Country Link
US (1) US20080171784A1 (pl)
EP (1) EP1653930B1 (pl)
AT (1) ATE381322T1 (pl)
CA (1) CA2535225A1 (pl)
DE (1) DE602004010817T2 (pl)
EA (1) EA007345B1 (pl)
ES (1) ES2298763T3 (pl)
HR (1) HRP20060089B1 (pl)
PL (2) PL1653930T3 (pl)
PT (1) PT1653930E (pl)
RS (1) RS20060081A (pl)
SK (1) SK50462005A3 (pl)
WO (1) WO2005011638A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674923B2 (en) * 2004-09-28 2010-03-09 Teva Pharmaceutical Industries Ltd Process for preparing forms of atorvastatin calcium substantially free of impurities
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
EP1741427A1 (en) * 2005-07-06 2007-01-10 KRKA, D.D., Novo Mesto Pharmaceutical composition comprising simvastatin and ezetimibe
CA2547216A1 (en) 2005-09-21 2007-03-21 Renuka D. Reddy Process for annealing amorphous atorvastatin
EP1810667A1 (en) 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising amorphous atorvastatin
CZ300047B6 (cs) * 2007-03-02 2009-01-21 Zentiva, A. S. Farmaceutická kompozice s obsahem úcinné látky atorvastatinu
EP2127628A1 (en) 2008-05-27 2009-12-02 Ranbaxy Laboratories Limited Unit dose pack
TR200806300A2 (tr) * 2008-08-22 2010-03-22 B�Lg�� Mahmut Çözünürlük artırıcı farmasötlk formulasyon
EP2522348B1 (en) 2009-12-25 2016-05-25 Sawai Pharmaceutical Co., Ltd. Atorvastatin-containing coated preparation
US9717707B2 (en) 2011-12-08 2017-08-01 Hexal Ag Pharmaceutical statin composition
TWI636783B (zh) * 2012-04-18 2018-10-01 友霖生技醫藥股份有限公司 含匹伐他汀（ｐｉｔａｖａｓｔａｔｉｎ）穩定配方的醫藥組合物
ES2695158T3 (es) 2013-03-14 2019-01-02 Fresenius Kabi Deutschland Gmbh Sistema de envasado para fármacos sensibles al oxígeno
WO2014140095A1 (en) 2013-03-14 2014-09-18 Becton Dickinson France S.A.S. Injectable morphine formulations
EP3184103A1 (en) 2015-12-21 2017-06-28 Hexal AG Pharmaceutical composition comprising atorvastatin or a salt thereof
EP3272336A1 (de) 2016-07-19 2018-01-24 Stada Arzneimittel Ag Atorvastatin-zusammensetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
JP3254219B2 (ja) * 1993-01-19 2002-02-04 ワーナー−ランバート・コンパニー 安定な経口用のｃｉ−９８１製剤およびその製法
ATE418979T2 (de) * 2000-06-09 2009-01-15 Lek Pharmaceuticals Stabilisiertes arzneimittel und arzneizubereitung
EP1243524A3 (en) * 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
EP1241110A1 (en) * 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
CA2475722A1 (en) * 2002-02-14 2003-08-21 Romi Barat Singh Formulations of atorvastatin stabilized with alkali metal additions
SI21302A (sl) * 2002-10-11 2004-04-30 LEK farmacevtska dru�ba d.d. Stabiliziran farmacevtski izdelek z amorfno aktivno učinkovino

Also Published As

Publication number Publication date
US20080171784A1 (en) 2008-07-17
HRP20060089B1 (en) 2008-05-31
DE602004010817T2 (de) 2008-12-11
SK50462005A3 (sk) 2005-09-08
EA007345B1 (ru) 2006-08-25
EP1653930A2 (en) 2006-05-10
WO2005011638A2 (en) 2005-02-10
PL379195A1 (pl) 2006-07-24
PT1653930E (pt) 2008-03-12
EP1653930B1 (en) 2007-12-19
HRP20060089A2 (en) 2006-05-31
CA2535225A1 (en) 2005-02-10
ES2298763T3 (es) 2008-05-16
RS20060081A (sr) 2008-06-05
EA200500819A1 (ru) 2006-02-24
WO2005011638A3 (en) 2005-10-20
ATE381322T1 (de) 2008-01-15
DE602004010817D1 (de) 2008-01-31

Similar Documents

Publication Publication Date Title
PT1653930E (pt) Métodos para a estabilização da atorvastatina
AP1880A (en) Method for obtaining aqueous formulations of oxidation sensitive active principles.
NZ504739A (en) Treating Meat products by chilling and adding a carbon dioxide containing gas
AR022866A1 (es) Conjunto que comprende una bebida envasada lista para beber y dicha bebida envasada lista para beber.
GR3025966T3 (en) Method for manufacturing and storing stable bicarbonate solutions.
WO2005122774A3 (en) Packaging of meat prodcuts with modified atmospheres and/or enhancers
AU2002365135A1 (en) Integrated oxygen generation and carbon dioxide absorption method, apparatus and systems
AU2003301519A1 (en) Method and apparatus for filling portable high pressure cylinders with respiratory oxygen
IL128801A (en) Pharmaceutical composition comprising a substance inhibiting no synthase
NZ507635A (en) Modifying the atmosphere in a refrigerated container using an apparatus to withdraw gaseous by-products and filter the by-products prior to its return
WO2004054493A3 (en) Portable hypoxic apparatus
TW200626370A (en) Roller micro-contact printer with pressure control
WO2005108544A3 (en) Meat pproduct package and packaging method with maintained atmosphere
WO2004002390A3 (en) Therapeutic agent delivery device and method
AU2002224020A1 (en) Catalysts comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalysts
DE602005026905D1 (de) Produktabgabesystem und dessen herstellungsverfahren
EP1273420A3 (en) Method and apparatus for supplying resin material to injection molder, and foamed product
MY141989A (en) Drug delivery assembly
TW200706232A (en) Gas separating device and gas separating method
WO2003037388A3 (en) System and method for de-contaminating and/or sanitizing
EP1900641A3 (en) System for packaging minimally processed fresh vegetable products
WO2008079947A3 (en) Gaseous sterilization of impermeable containers through use of porous material
WO2002026059A3 (en) Method for preserving food products using biological modified atmosphere packaging
TW200639117A (en) Fuel cell
AU2002214090A1 (en) Method and installation for packaging a liquid product in a package